BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29974943)

  • 1. Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
    Stosch JM; Heumüller A; Niemöller C; Bleul S; Rothenberg-Thurley M; Riba J; Renz N; Szarc Vel Szic K; Pfeifer D; Follo M; Pahl HL; Zimmermann S; Duyster J; Wehrle J; Lübbert M; Metzeler KH; Claus R; Becker H
    Br J Haematol; 2018 Sep; 182(6):830-842. PubMed ID: 29974943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal architecture of secondary acute myeloid leukemia.
    Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
    N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
    Calleja A; Yun S; Moreilhon C; Karsenti JM; Gastaud L; Mannone L; Komrokji R; Al Ali N; Dadone-Montaudie B; Robert G; Auberger P; Raynaud S; Sallman DA; Cluzeau T
    Eur J Haematol; 2020 May; 104(5):488-498. PubMed ID: 31990086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of progression from MDS to secondary leukemia.
    Menssen AJ; Walter MJ
    Blood; 2020 Jul; 136(1):50-60. PubMed ID: 32430504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.
    Kao HW; Sanada M; Liang DC; Lai CL; Lee EH; Kuo MC; Lin TL; Shih YS; Wu JH; Huang CF; Ogawa S; Shih LY
    Neoplasia; 2011 Nov; 13(11):1035-42. PubMed ID: 22131879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.
    Nakajima H
    Intern Med; 2021 Jan; 60(1):15-23. PubMed ID: 32009100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.
    Layton DM; Mufti GJ
    Blut; 1986 Dec; 53(6):423-36. PubMed ID: 3542084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level.
    Chen J; Kao YR; Sun D; Todorova TI; Reynolds D; Narayanagari SR; Montagna C; Will B; Verma A; Steidl U
    Nat Med; 2019 Jan; 25(1):103-110. PubMed ID: 30510255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
    Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
    Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
    Walter MJ; Shen D; Shao J; Ding L; White BS; Kandoth C; Miller CA; Niu B; McLellan MD; Dees ND; Fulton R; Elliot K; Heath S; Grillot M; Westervelt P; Link DC; DiPersio JF; Mardis E; Ley TJ; Wilson RK; Graubert TA
    Leukemia; 2013 Jun; 27(6):1275-82. PubMed ID: 23443460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clonal origins of leukemic progression of myelodysplasia.
    Kim T; Tyndel MS; Kim HJ; Ahn JS; Choi SH; Park HJ; Kim YK; Yang DH; Lee JJ; Jung SH; Kim SY; Min YH; Cheong JW; Sohn SK; Moon JH; Choi M; Lee M; Zhang Z; Kim DDH
    Leukemia; 2017 Sep; 31(9):1928-1935. PubMed ID: 28090092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia.
    Guess T; Potts CR; Bhat P; Cartailler JA; Brooks A; Holt C; Yenamandra A; Wheeler FC; Savona MR; Cartailler JP; Ferrell PB
    Blood Cancer Discov; 2022 Jul; 3(4):316-329. PubMed ID: 35522837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2
    Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L
    Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress on mechanism of MDS transformation into AML].
    Wang LL; Gao C; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):254-9. PubMed ID: 21362264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.
    Sperling AS; Gibson CJ; Ebert BL
    Nat Rev Cancer; 2017 Jan; 17(1):5-19. PubMed ID: 27834397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of MDS.
    Ogawa S
    Blood; 2019 Mar; 133(10):1049-1059. PubMed ID: 30670442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.